Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril valsartan vs amlodipine on vascular elasticity in essential hypertension with early vascular aging
ChiCTR2200065148Phase 4Recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan in essential hypertension (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Pulse wave velocity. Started Nov 2022; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2200065148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065148.